Erlotinib encapsulated oral chitosan modified lipid nanoparticles for lung cancer
Abstract
Lung cancer ranks among the leading factors behind cancer-related fatalities across the globe. Erlotinib (ERT) is one of the frontline drugs used for lung cancer. However, ERT shows poor aqueous solubility, dissolution, gastrointestinal absorption, bioavailability, and therapeutic efficacy. Therefore, this study was planned to prepare…